docetaxel,carboplatin
sanofi,aventis
['tnbc', 'docetaxel', 'carboplatin']
#esmo22: pcr and early survival data according to tnbctype4 classifier in operable tnbc treated with neoadjuvant carboplatin and docetaxel: pcr in bl1/2, pcr in lar; no association with survival (trend for ddfs in bl1 and for lar) 
MD, Medical Oncologist????•Research Fellow at @JulesBordet Institute in Brussels???? Great interest in #BreastCancer and #ImmunoOncology